High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments

Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) have become the preferred therapy as first-line treatment of non-small cell lung cancer patients harboring sensitizing EGFR mutations. However, the prognostic indicators are limited. The present study aimed to assess the prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiayan, Zhang, Na, Zhang, Haixia, Liu, Ping, Ma, Jinan, Hu, Chunhong, Liu, Xianling, Hou, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668471/
https://www.ncbi.nlm.nih.gov/pubmed/33181687
http://dx.doi.org/10.1097/MD.0000000000023150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668471/
https://www.ncbi.nlm.nih.gov/pubmed/33181687
http://dx.doi.org/10.1097/MD.0000000000023150

Ejemplares similares